Aktie A0LCP6 JHS SVENDGAARD LABORATORIES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen JHS Svendgaard Laboratories Limited Bombay S.E.

Aktien

A0LCP6

INE544H01014

JHS

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:00:52 07.06.2024 		% 5 Tage % 1. Jan.
20.7 INR +1.32% Intraday Chart für JHS Svendgaard Laboratories Limited +3.71% -18.82%
05.03. JHS Svendgaard Laboratories Limited (NSEI:JHS) hat die Transaktion von Vedic Cosmeceuticals Pvt. Ltd. abgesagt. CI
14.02. JHS Svendgaard Laboratories Limited meldet Ergebnis für die neun Monate bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
JHS Svendgaard Laboratories Limited announced that it expects to receive INR 300 million in funding from COEUS Global Opportunities Fund, M.B. Finmart Private Limited, Milky Investment And Trading Company, Puran Associates Pvt. Ltd., Vic Enterprises Private Limited and another investor
JHS Svendgaard Laboratories Limited cancelled the transaction of Vedic Cosmeceuticals Pvt. Ltd.
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
JHS Svendgaard's Joint CFO Resigns
JHS Svendgaard Laboratories Limited Announces the Resignation of Mr. Deepesh Sharma as Joint Chief Financial Officer
JHS Svendgaard Laboratories Limited Announces Cessation of Rohina Sanjay Sangtani as Independent Director
JHS Svendgaard Laboratories Limited completed the Spin-Off of JHS Svendgaard Retail Ventures Private Limited.
JHS Svendgaard Laboratories Limited agreed to acquire Vedic Cosmeceuticals Pvt. Ltd.
JHS Svendgaard Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
JHS Svendgaard Laboratories Limited Appoints Deepesh Sharma as Joint Chief Financial Officer
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
JHS Svendgaard Laboratories Limited Announces the Resignation of Neeraj Kumar as Joint Chief Financial Officer, Effective March 15, 2023
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
JHS Svendgaard Laboratories Limited cancelled the transaction announced on September 2, 2022
JHS Svendgaard Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0LCP6 Aktie
  4. A0LCP6 Aktie
  5. Nachrichten JHS Svendgaard Laboratories Limited
  6. Andere Sprachen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT